Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicole R Grieselhuber

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Hematologic Malignancy Reports|March 19, 2021
Novel Targeted Therapeutics in Acute Myeloid Leukemia: an Embarrassment of RichesNicole R Grieselhuber, Alice S Mims
Surgery|November 11, 2017
Confronting the therapeutic misconceptionNicole R Grieselhuber, Ira J Kodner, Douglas Brown, et al.
Blood|July 22, 2010
A protease-resistant PML-RAR{alpha} has increased leukemogenic potential in a murine model of acute promyelocytic leukemiaGeoffrey L Uy, Andrew A Lane, John S Welch, et al.
Leukemia|March 5, 2013
Notch signaling in acute promyelocytic leukemiaNicole R Grieselhuber, Jeffery M Klco, Angela M Verdoni, et al.
The Journal of Clinical Investigation|May 20, 2009
High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samplesJacqueline E Payton, Nicole R Grieselhuber, Li-Wei Chang, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 14, 2020
The Incidence of Invasive Fungal Infections in Patients With AML Treated With a Hypomethylating AgentMichael Ozga, Ying Huang, James S Blachly, et al.
International Journal of Hematologic Oncology|October 5, 2020
Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemiaBrynne Underwood, Qiuhong Zhao, Alison R Walker, et al.
Leukemia & Lymphoma|September 19, 2017
Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemiaLeslie A Andritsos, Nicole R Grieselhuber, Mirela Anghelina, et al.
Hematological Oncology|October 29, 2021
Diagnostic utility of bronchoscopy in newly diagnosed acute leukemia patientsKristin L Koenig, Thomas P Curley, Shylaja Mani, et al.
Experimental Hematology & Oncology|March 4, 2024
The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signalingAlexander R Marr, Madeline Halpin, Dominique L Corbin, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Hematologic Malignancy Reports|March 19, 2021
Novel Targeted Therapeutics in Acute Myeloid Leukemia: an Embarrassment of RichesNicole R Grieselhuber, Alice S Mims
Surgery|November 11, 2017
Confronting the therapeutic misconceptionNicole R Grieselhuber, Ira J Kodner, Douglas Brown, et al.
Blood|July 22, 2010
A protease-resistant PML-RAR{alpha} has increased leukemogenic potential in a murine model of acute promyelocytic leukemiaGeoffrey L Uy, Andrew A Lane, John S Welch, et al.
Leukemia|March 5, 2013
Notch signaling in acute promyelocytic leukemiaNicole R Grieselhuber, Jeffery M Klco, Angela M Verdoni, et al.
The Journal of Clinical Investigation|May 20, 2009
High throughput digital quantification of mRNA abundance in primary human acute myeloid leukemia samplesJacqueline E Payton, Nicole R Grieselhuber, Li-Wei Chang, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 14, 2020
The Incidence of Invasive Fungal Infections in Patients With AML Treated With a Hypomethylating AgentMichael Ozga, Ying Huang, James S Blachly, et al.
International Journal of Hematologic Oncology|October 5, 2020
Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemiaBrynne Underwood, Qiuhong Zhao, Alison R Walker, et al.
Leukemia & Lymphoma|September 19, 2017
Trametinib for the treatment of IGHV4-34, MAP2K1-mutant variant hairy cell leukemiaLeslie A Andritsos, Nicole R Grieselhuber, Mirela Anghelina, et al.
Hematological Oncology|October 29, 2021
Diagnostic utility of bronchoscopy in newly diagnosed acute leukemia patientsKristin L Koenig, Thomas P Curley, Shylaja Mani, et al.
Experimental Hematology & Oncology|March 4, 2024
The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloid leukemia via inhibition of Wnt/β-catenin signalingAlexander R Marr, Madeline Halpin, Dominique L Corbin, et al.
Pageof 2